Since the SF-MSC treatment inhibited the increased IL-6 and decreased TGF-both of which are associated with Treg induction, we hypothesized that SF-MSC treatment could induce differentiation of Tregs in BLM-treated mice and prevent lung fibrosis. Here, IL6 is linked to pulmonary fibrosis.